Author: Lilly Matson

Recently, news of a COVID-19 vaccine has dominated headlines. We’ve summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

Labs and research institutions are responsible for a huge amount of waste. We spoke to 3 researchers who are taking the problem into their own hands.

Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.

Scientists at the Wellcome Sanger Institute have discovered that that genetic structure of the placenta contains many of the same genetic mutations found in children’s cancers.

An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients.

Joining forces with Children with Cancer UK, we’re proud to be co-funding the Cancer Research UK–Children with Cancer UK Innovation Awards.

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.